Instruction for use
The composition of the drug:
active substance: 1 tablet contains: Gentiana D1 3.6 mg Aconitum D6 37.2 mg Bryonia D6-37,2 mg, Ferrum phosphoricum D12 37.2 mg sarcolacticum Acidum D12-37,2 mg;
excipients: lactose monohydrate, potato starch, magnesium stearate.
Dosage form. Drops for oral use.
The name and location of manufacturer. Richard Bittner AG, Ossahatchee 7, A-9560 Velden, Austria.
Pharmacotherapeutic group. Complex homeopathic drug.
The drug has a direct antiviral effect and stimulates the synthesis of interferon and cell-mediated immunity that allows it to be used at different stages of the infectious process (both for prevention and for treatment).
In the medical usage of the drug eliminates the chills and normalizes temperature; relieves inflammation of the upper respiratory tract, runny nose and cough; reduces headaches and eliminates weakness; reduces pain in muscles and joints, activates the body's defenses; double speed recovery, prevent complications, and effective for the treatment of children, adults and the elderly.
When used with preventive purpose the drug strengthens the overall resistance of the organism; increases local immunity of the upper respiratory tract; reduces the likelihood of influenza and colds.
Indications for use. Prevention and treatment of influenza and ARVI (acute respiratory viral infections), as well as in complex treatment of inflammatory and rheumatic diseases with pain in the joints.
Contraindications. Hypersensitivity (Allergy) to any component of the drug.
Dosage form of tablets contains lactose, therefore patients with rare hereditary forms of intolerance to galactose, lactase insufficiency, or syndrome of glucose-galactose malabsorption is Aflubin tablets should be taken the drug in the form of drops.
As Aflubin® contains natural plant components during storage may experience a slight change in the taste and color of the pill that does not reduce the effectiveness of the drug.
Use during pregnancy or breast-feeding. Information regarding any risk to the fetus and the child from the use of drugs during pregnancy and lactation has so far not registered. The drug can be used during pregnancy or breastfeeding, in cases when expected benefit for mother exceeds potential risk for fetus/baby.
The ability to influence the rate of reaction at management of motor transport or operating other mechanisms. The drug does not affect ability to operate vehicles and mechanical means.
Children. To treat children up to 5 years using the drug Aflubin® in the form of drops.
Overdose. Overdoses are not detected.
Side effects. In exceptional cases, patients with hypersensitivity to any component of the drug, possible allergic reactions.
Interaction with other medicinal products and other forms of interaction. Clinically important interactions drug Aflubin® with other drugs is not established. The drug can be combined with other medicines and methods of treatment.
The expiration date. 3 years.
The storage conditions. Store in original carton at a temperature not above 30 °C and out of reach of children.